Polaris of San Diego to Build $50 Million Facility in Chengdu
3/1/2013 11:16:18 AM
More...
|
Polaris, Johnson & Johnson (JNJ) Hatch Idea to Solve Drug R&D Crisis: Work Together Early
6/14/2012 8:19:36 AM
More...
|
Polaris is the Winner of the 2011 Pierre Potier Price Trophy for its Innovation in Chemistry in Favour of Sustainable Development
7/12/2011 9:45:07 AM
More...
|
Ludwig Institute For Cancer Research (LICR) and Polaris Form Collaboration to Expand Development of Polaris' Novel Cancer Drug, ADI-PEG 20
5/18/2011 9:15:10 AM
More...
|
Polaris to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
5/12/2011 7:06:14 AM
More...
|
Polaris Release: Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
4/11/2011 8:50:27 AM
More...
|
Polaris Release: Transcriptional Silencing of ASS1 Suggests the Potential Use of ADI-PEG 20 to Treat AML, Glioblastoma and Bladder Cancer
4/8/2011 7:04:12 AM
More...
|
FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
3/31/2011 11:35:12 AM
More...
|
FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
3/31/2011 7:10:01 AM
More...
|
Polaris Enrolls First Patient in Phase 2 Clinical Trial of ADI-PEG 20 for the Treatment of Malignant Mesothelioma
3/18/2011 8:35:41 AM
More...
|
|